Yuji Ozeki - Publications

Affiliations: 
Dokkyo Medical University 

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Akiyama K, Saito A, Saito S, Ozeki Y, Watanabe T, Fujii K, Shimoda K. Association of genetic variants at 22q11.2 chromosomal region with cognitive performance in Japanese patients with schizophrenia. Schizophrenia Research. Cognition. 17: 100134. PMID 31193788 DOI: 10.1016/j.scog.2019.100134  0.424
2019 Fujii K, Maekawa M, Ozeki Y, Eto Y, Saito T, Shinozaki M, Arime Y, Nagashima T, Okayasu H, Ishii S, Shimoda K. F17. Examination Of The Findings Suggesting Niemann–Pick Disease Type C In Patients With Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.429  0.395
2018 Ono S, Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Okamoto K, Sagae T, Someya T. High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey. Bmc Psychiatry. 18: 180. PMID 29879941 DOI: 10.1186/s12888-018-1764-1  0.405
2018 Teraishi T, Kajiwara M, Hori H, Sasayama D, Hidese S, Matsuo J, Ishida I, Kajiwara Y, Ozeki Y, Ota M, Hattori K, Higuchi T, Kunugi H. C-phenylalanine breath test and serum biopterin in schizophrenia, bipolar disorder and major depressive disorder. Journal of Psychiatric Research. 99: 142-150. PMID 29454221 DOI: 10.1016/j.jpsychires.2018.01.019  0.459
2018 Akiyama K, Saito S, Ozeki Y, Fujii K, Watanabe T, Shimoda K, Honda G, Mori H. S195. Processing Speed and Negative Symptoms Predict Functional Outcomes Assessed in Later Years in Japanese Patients With Schizophrenia Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1087  0.373
2017 Sugawara N, Sagae T, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Ozeki Y, Okamoto K, Someya T. Effects of nutritional education on weight change and metabolic abnormalities among patients with schizophrenia in Japan: A randomized controlled trial. Journal of Psychiatric Research. 97: 77-83. PMID 29220825 DOI: 10.1016/j.jpsychires.2017.12.002  0.371
2017 Sugawara N, Maruo K, Sugai T, Suzuki Y, Ozeki Y, Shimoda K, Someya T, Yasui-Furukori N. Prevalence of underweight in patients with schizophrenia: A meta-analysis. Schizophrenia Research. PMID 29054486 DOI: 10.1016/j.schres.2017.10.017  0.399
2017 Ozeki Y, Sekine M, Fujii K, Watanabe T, Okayasu H, Takano Y, Shinozaki T, Aoki A, Aoki H, Mori H, Akiyama K, Homma H, Shimoda K. M6. Relationship Between Peripheral Amino Acid Concentration and Diagnosis and Severity of Schizophrenia Using Structural Equation Modeling Analysis Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.005  0.348
2016 Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T. High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey. Plos One. 11: e0166429. PMID 27855222 DOI: 10.1371/journal.pone.0166429  0.352
2016 Akiyama K, Saito S, Saito A, Ozeki Y, Watanabe T, Fujii K, Honda G, Shimoda K. Predictive value of premorbid IQ, negative symptoms, and age for cognitive and social functions in Japanese patients with schizophrenia: A study using the Japanese version of the Brief Assessment of Cognition in Schizophrenia. Psychiatry Research. PMID 27838018 DOI: 10.1016/j.psychres.2016.10.070  0.417
2016 Takano Y, Ozeki Y, Sekine M, Fujii K, Watanabe T, Okayasu H, Shinozaki T, Aoki A, Akiyama K, Homma H, Shimoda K. Multi-regression analysis revealed a relationship between l-serine and methionine, a component of one-carbon metabolism, in the normal control but not in the schizophrenia. Annals of General Psychiatry. 15: 23. PMID 27588034 DOI: 10.1186/s12991-016-0113-3  0.381
2016 Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Minami Y, Ozeki Y, Okamoto K, Sagae T, Someya T. Attitudes toward metabolic adverse events among patients with schizophrenia in Japan. Neuropsychiatric Disease and Treatment. 12: 427-36. PMID 26966364 DOI: 10.2147/NDT.S98711  0.409
2016 Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T. Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey. Schizophrenia Research. PMID 26811231 DOI: 10.1016/j.schres.2016.01.016  0.414
2016 Ozeki Y, Sekine M, Fujii K, Watanabe T, Okayasu H, Takano Y, Shinozaki T, Aoki A, Akiyama K, Homma H, Shimoda K. Phosphoserine phosphatase activity is elevated and correlates negatively with plasma d-serine concentration in patients with schizophrenia. Psychiatry Research. PMID 26804975 DOI: 10.1016/j.psychres.2016.01.010  0.427
2015 Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T. High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey. Bmj Open. 5: e008720. PMID 26656016 DOI: 10.1136/bmjopen-2015-008720  0.428
2014 Fujii K, Ozeki Y, Okayasu H, Takano Y, Shinozaki T, Hori H, Orui M, Horie M, Kunugi H, Shimoda K. QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects. Plos One. 9: e98555. PMID 24887423 DOI: 10.1371/journal.pone.0098555  0.443
2013 Kuratomi G, Saito A, Ozeki Y, Watanabe T, Fujii K, Shimoda K, Inukai T, Mori H, Ohmori K, Akiyama K. Association of the Hermansky-Pudlak syndrome type 4 (HPS4) gene variants with cognitive function in patients with schizophrenia and healthy subjects. Bmc Psychiatry. 13: 276. PMID 24168225 DOI: 10.1186/1471-244X-13-276  0.396
2013 Saito A, Kuratomi G, Ito C, Matsuoka H, Suzuki T, Ozeki Y, Watanabe T, Fujii K, Shimoda K, Fukushima Y, Inukai T, Ohmori K, Akiyama K. An association study of the Hermansky-Pudlak syndrome type 4 gene in schizophrenic patients. Psychiatric Genetics. 23: 163-73. PMID 23563589 DOI: 10.1097/YPG.0b013e32836130a9  0.363
2013 Okayasu H, Ozeki Y, Chida M, Miyoshi S, Shimoda K. Lung transplantation in a Japanese patient with schizophrenia from brain-dead donor. General Hospital Psychiatry. 35: 102.e11-3. PMID 22542053 DOI: 10.1016/j.genhosppsych.2012.03.013  0.371
2013 Teraishi T, Ozeki Y, Hori H, Sasayama D, Chiba S, Yamamoto N, Tanaka H, Iijima Y, Matsuo J, Kawamoto Y, Kinoshita Y, Hattori K, Ota M, Kajiwara M, Terada S, et al. 1219 – Phenylalanine kinetics in schizophrenia patients detected by 13C-phenylalanine breath test European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)76299-0  0.414
2012 Teraishi T, Ozeki Y, Hori H, Sasayama D, Chiba S, Yamamoto N, Tanaka H, Iijima Y, Matsuo J, Kawamoto Y, Kinoshita Y, Hattori K, Ota M, Kajiwara M, Terada S, et al. 13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients. Translational Psychiatry. 2: e119. PMID 22832963 DOI: 10.1038/tp.2012.48  0.409
2011 Hori H, Teraishi T, Ozeki Y, Hattori K, Sasayama D, Matsuo J, Kawamoto Y, Kinoshita Y, Higuchi T, Kunugi H. Schizotypal personality in healthy adults is related to blunted cortisol responses to the combined dexamethasone/ corticotropin-releasing hormone test. Neuropsychobiology. 63: 232-41. PMID 21494051 DOI: 10.1159/000322146  0.351
2011 Ozeki Y, Pickard BS, Kano S, Malloy MP, Zeledon M, Sun DQ, Fujii K, Wakui K, Shirayama Y, Fukushima Y, Kunugi H, Hashimoto K, Muir WJ, Blackwood DH, Sawa A. A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression. Neuroscience Research. 69: 154-60. PMID 20955740 DOI: 10.1016/J.Neures.2010.10.003  0.672
2008 Ozeki Y, Mizuguchi T, Hirabayashi N, Ogawa M, Ohmura N, Moriuchi M, Harada N, Matsumoto N, Kunugi H. A Case of Schizophrenia with Chromosomal Microdeletion of 17p11.2 Containing a Myelin-Related Gene PMP22 The Open Psychiatry Journal. 2: 1-4. DOI: 10.2174/1874354400802010001  0.436
2008 Ozeki Y, Fujii K, Kurimoto N, Tsuji K, Yamada N, Okawa M, Aoki T, Takahashi J, Ishida N, Narita M, Saito O, Horie M, Kunugi H. 332 – Risk factors of qt interval prolongation in 1000 patients with schizophrenia Schizophrenia Research. 98: 170. DOI: 10.1016/J.Schres.2007.12.399  0.408
2006 Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, Roberts RC. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. The Journal of Comparative Neurology. 497: 436-50. PMID 16736468 DOI: 10.1002/Cne.21007  0.485
2006 Fujii K, Maeda K, Hikida T, Mustafa AK, Balkissoon R, Xia J, Yamada T, Ozeki Y, Kawahara R, Okawa M, Huganir RL, Ujike H, Snyder SH, Sawa A. Serine racemase binds to PICK1: potential relevance to schizophrenia. Molecular Psychiatry. 11: 150-7. PMID 16314870 DOI: 10.1038/Sj.Mp.4001776  0.68
2005 Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y, Sawamura N, Park U, Kudo C, Okawa M, Ross CA, Hatten ME, Nakajima K, Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nature Cell Biology. 7: 1167-78. PMID 16299498 DOI: 10.1038/Ncb1328  0.678
2005 Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah JH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nature Cell Biology. 7: 665-74. PMID 15951807 DOI: 10.1038/Ncb1268  0.692
2005 Sawa A, Nagata E, Sutcliffe S, Dulloor P, Cascio MB, Ozeki Y, Roy S, Ross CA, Snyder SH. Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts. Neurobiology of Disease. 20: 267-74. PMID 15890517 DOI: 10.1016/J.Nbd.2005.02.013  0.541
2005 Sawamura N, Sawamura-Yamamoto T, Ozeki Y, Ross CA, Sawa A. A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuse. Proceedings of the National Academy of Sciences of the United States of America. 102: 1187-92. PMID 15657124 DOI: 10.1073/Pnas.0406543102  0.501
2004 Ozeki Y, Okawa M, Sawa A. [DISC1 and schizophrenia]. Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology. 24: 87-91. PMID 15164617  0.542
2004 Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K, Okawa M, Yamada N, Hatten ME, Snyder SH, Ross CA, Sawa A. Erratum: Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth (Proceedings of the National Academy of Sciences of the United States of America (January 7, 2003) 100, 1 (289-294)) Proceedings of the National Academy of Sciences of the United States of America. 101. DOI: 10.1073/Pnas.0405527101  0.673
2003 Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K, Okawa M, Yamada N, Hatten ME, Snyder SH, Ross CA, Sawa A. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proceedings of the National Academy of Sciences of the United States of America. 100: 289-94. PMID 12506198 DOI: 10.1073/Pnas.0136913100  0.69
2003 Kirkpatrick B, Cascella N, Ozeki Y, Roberts R, Sawa A. DISC1-immunoreactive cells in the human brain Schizophrenia Research. 60: 72. DOI: 10.1016/S0920-9964(03)80599-6  0.403
Show low-probability matches.